Risk Evaluation and Mitigation Strategy Innovation Summit

Memo

Innovating in the REMS space is critical, not only talking about technology but also talking about the approach with the FDA, the processes and the way we communicate with all the stakeholders. The vendor playing field has levelled due to McKesson leaving the REMS space. This event will explore the technology leveraged successfully with REMS and how it can improve the patient experience. This REMS Innovation Summit focuses solely on the REMS and does deviate into commonly associated areas such as pharmacovigilance. In order to drive innovation and problem solving on behalf of the patients, there must be a dedicated forum to optimizing REMS programs. This is it. TOP REASONS TO ATTEND:- Learn how to work with the Solution Providers in the REMS space: understanding the requirements and offerings from companies in the space and what you need to look for when it comes to vendor partner opportunities.- Evaluate Strategic Partnerships with fellow industry partners: work together to create better understanding and relationships with the FDA.- Explore different technologies that serve the patients and decrease the toll on stakeholders, to truly deliver on a patient centric approach.- Understand the impact and growth from telemedicine and how to accommodate in the REMS space.- Master the guidances on when and how to plan specifics for your REMS strategy in a post/during -Covid world.- Introduce innovation in REMS from every possible angle; from technology, patient centric and FDA approach, solution provider opportunity to satisfy the ongoing needs from REMS. URL:Tickets: https://go.evvnt.com/849138-1?pid=5569 Price:General Admission from: USD 695.0 Date and Time: On Monday October 18, 2021 at 8:00 am (ends Tuesday October 19, 2021 at 5:00 pm)